Azelis has agreed to distribute Novo Nordisk Pharmatech’s pharmaceutical-grade quaternary ammonium compounds (quats) to the pharmaceutical and medical device markets in Germany, Spain, Portugal, UK and Ireland.

Matthew Dickman, market segment director pharma at Azelis, said the Danish group’s range of quats complements the distributor’s existing portfolio of pharma antimicrobials. “Alongside established uses of quats, our pharma experts see potential new applications in the growing wound care market,” he said, adding that Azelis teams will be investigating these options in the coming period.

In separate news, the Luxembourg-headquartered distributor has achieved COSMOS (COSMetic Organic Standard) certification for its organic specialties business in the UK. The Europe-wide standard replaces and combines five former accreditations: BDIH (Germany); Cosmebio (France); Ecocert Greenlife SAS (France); ICEA (Italy) and Soil Association (UK).

Azelis said the COSMOS certification will allow the company to open up new markets and boost sales for its organic specialties range. Companies certified by COSMOS must be continually assessed and undergo a physical site inspection every year to ensure compliance with the standard.